Metabolism and pharmacokinetics of alternate drinking water disinfectants. by Abdel-Rahman, M S et al.
Environmental Health Perspectives
Vol. 46, pp. 19-23, 1982
Metabolism and Pharmacokinetics of
Alternate Drinking Water Disinfectants
by Mohamed S. Abdel-Rahman,* Daniel Courit and
Richard J. BulItt
The chlorination of surface waters is known to elevate trihalomethanes; consequently,
chlorine dioxide (CI02) is being considered as an alternative disinfectant. The primary products
resulting from C102 disinfection ofwaters are chlorites (CIO2-) and chlorates (C103-). Studies in
ratsrevealedthatC102isconvertedtochloride(ClI), CIO2-andCIO3-. C1O2-andCIO3-areexcreted
as Cl1, C102- and Cl-, C102-, Cl03-, respectively. Radioactivity was rapidly absorbed from the
gastrointestinal tract following the administration of 'CIO2 orally, and the half-life for the
elimination of3Cl from the rat was 44 hr, corresponding to a rate constant of0.016/hr. After 72
hr, radioactivity was highest in plasma, followed by kidney, lung, and stomach. 36CI in plasma
reached a peak at 2 hr and 1 hrafter oral administration of36C102- and36CI03-, respectively. 3Cl
excretion was greatest 24 hr after the administration of36CI03-, but in the case of 'CI02-, the
excretion probably represented saturation of the biotransformation and excretion pathway. A
low activity in packed cells compared to plasma was detected in chlorate ingestion, rather than
an even distribution in chlorite treatment. Chloroform determinations in rat blood afterone year
indicated that chloroform was significantly higher than control in the 100 and 1000 mg/l. C102
groups. However, no significant values were observed in the 1 or 10 mg/I. C102 and C102
metabolites group. C102 and its metabolites are eliminated from the body more rapidly than
chlorine, and they do not appear to increase trihalomethane concentrations at low dosages.
Introduction
Chlorination is, and always has been, the most
widely used method for disinfection ofpublic water
supplies. Concern over its possible adverse effects
andthose ofitsby-products onhumanshasincreased
considerably in recent years. The formation of
trihalomethanes such as chloroform (CHC13), bromo-
dichloromethane(CHBrC12),dibromochloromethane
(CHBr2Cl) and bromoform (CHBr3) during the
chlorination process has become evident (1, 2).
The United States Environmental Protection
Agency conducted a comprehensive survey of 80
water supplies in the U.S. for halogenated organics
(3). It was found that the four trihalomethanes
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CHCl3, CHBrCI2, CHBr2CI, CHBr3-arewidespread
in chlorinated drinking waterin the U.S. and result
from chlorination, since these substances were not
found in raw waters. The trihalomethanes were not
a result ofimpurities in the chlorine being used but
were a result of the reaction of chlorine with
precursor. Morris (4) made the point that the
number of trihalomethane precursors is extensive
and includes ethanol, acetaldehyde and the methyl
ketones. Rook (1) and Morris (4) indicated that the
bromide ion present in a natural water is rapidly
oxidized by aqueous chlorine to hypobromous acid
(HOBr), and that this acid reacts with precursor to
account for the formation of the brominated spe-
cies.
Since these trihalomethanes may be a health
hazard, chlorine dioxide (CI02) is one ofthe alterna-
tive disinfectants being considered because it pre-
vents the formation oftrihalomethanes (5, 6). C102
is amore effective oxidizingagentthan chlorine and
greatlyimproves the taste ofwaterby avoiding the
unpleasant taste associated with chlorination of20
water (7). The unpleasant taste ofchlorine in water
is caused partially by the build-up of chlorinated
phenols.
Miltner (6) has reported that the primary prod-
ucts resulting from C102 disinfection of surface
watersincludechlorites(01021andchlorates(C1030,
which appear in concentrations of 50% and 30% of
C102 demand, respectively.
Toxicity studies demonstrated that rats drinking
C102, C102- and C103- (Cl compounds) daily for 9
months exhibited depressed red blood cell counts,
hemoglobin concentration and packed cell volumes.
Also, these C1 compounds in drinking water for
three months inhibited the incorporation of 3H-
thymidine into nuclei of rat testes (8).
The studies described in this report were con-
ducted to provide information on metabolism and
pharmacokinetics ofchlorine, chlorine dioxide, chlo-
rite and chlorate in the rat. Also, the effect ofC102
in drinking water on the formation of CHC13 in rat
blood and various organs was studied.
Methods
Synthesis of 36C1 Compounds
H36C1 was obtained from New England Nuclear.
This material, with a radionuclidic purity of > 99%
was used as the source of 36C1. The potassium
chlorate (K36C103) was synthesized accordingtothe
method ofAbdel-Rahman et al. (9). The generation
of 36C102 from K36C103 was accomplished by the
reaction (1). 36C12 was formed by the reaction (2).
2K36C103 + (COOH)2 + 2H2SO4
236C102 + 2KHS04 + 2C02 +2H20 (1)
KMnO4 + 16H36C1 -* 2K36C1 + Mn36CI2 + 536C12 + 8H20 (2)
The purity of the synthesized K36C103, which is
an essential intermediate step to the production of
C102, was 95%, as determined by fast neutron
activation analysis.
Kinetics of Chlorine Dioxide, Chlorite,
Chlorate and Chlorine in the Rat
Four groups of four male Sprague-Dawley rats
(230 ± 20 g) each were used in these experiments.
36C0 compounds were administered by gavage as
follows: 3 ml of 100 mg/I. 36C102 (0.7 ,uCi) was
administered to each rat, producing a dose of 1.5
mg/kgbodyweight;3mlof10mg/ 36CIO2-(0.17,ui)
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was administered to each rat, producing a dose of
0.15mg/kgbodyweight; 3mlof5mg/I.36CO3-(0.85
,uCi) was administered to each rat, producing a
dose of0.065 mg/kg body weight; 3 ml of250 mg/I.
H036C1 (0.45 ,uCi) was administered to each rat,
producing a dose of3.26 mg/kg body weight.
Heparinized blood samples were collected at 5,
10, 20, 30 and 60 min, and 2, 4, 8, 24 and 48 hr by
orbital sinus puncture. The blood was centrifuged
at lOOOg for 15 min to separate the red blood cells
fromtheplasma. Thentheradioactivitywascounted
in a liquid scintillation counter (Beckman LS 7500),
and the rate constant and T1/2 of absorption and
elimination from plasma were calculated for each
compound.
Distribution of Cl Compounds in the
Rat
After 72 hr following the administration of 36C1
compounds asdescribedpreviously, ratswerekilled
by decapitation, and blood was collected in heparin-
ized tubes. Tissue specimens of stomach, testes,
lung, kidney, duodenum, ileum, spleen, liver, bone
marrow, carcass and skin were prepared for the
determination of36C1 content by liquid scintillation
spectrometry as follows: Whole blood and packed
cells were prepared according to the method of
Mahin et al. (10). Samples ofwettissue weighingup
to 200 mg and samples ofbone marrow up to 50 mg
were placed in individual glass LSC vials with
Teflonorpolyethylene-linedcaps. Then2mlProtosol
was added to each vial, which was capped tightly to
prevent loss of solvent. Samples were solubilized
by heating overnight at 5000, then cooled at room
temperature; afterwards 0.2 ml of 30% H202 was
added for decolorization. The samples were heated
at 5000 for 30 min, then cooled, and 15 ml of
Aquasol-2 was added.
Sample quench effects were corrected by using
the method of channel ratios, and efficiency was
greater than 80%.
Metabolism and Excretion Studies
Four groups of four male Sprague-Dawley rats/
group were used in these studies. Each group was
administered orally the same concentrations of36C1
compounds described above. Animals were housed
in modified Roth all-glass metabolism chambers for
the collection of expired air and fecal and urine
samples. The radioactivity of the total 36C1 com-
pounds was measured. The analysis of radioactive
metabolites (W-, C102-, C1031 was performed as
described in aprevious report, (9), and measured as
a percentage ofthe initial dose.PHARMACOKINETICS OF CHLORINE COMPOUNDS
Effect of Chlorine Dioxide, Chlorite
and Chlorate on the Formation of
Chloroform in Rat Blood and Organs
Male Sprague-Dawley rats (50-170 g) were used
in this experiment. The animals were housed in a
controlled environment (temperature, 22°C; humid-
ity 50%) with a 12 hr light/dark cycle beginning at
6:00 A.M. Food was available ad libitum. Groups of
rats were allowed to drink doubly distilled water
containing 10 or 100mg/l. C102, C102- orC103-for20
hr/day, 7 days/week for 12 months. C102 was gener-
ated daily and water concentrations determined by
the DPD (diethyl-p-phenylenediamine) method of
Palin (11).
After one year, rats were killed by decapitation
and blood collected in heparinized tubes. Tissue
samples of liver, kidney, spleen, brain, and testes
were homogenized in isotonic sucrose medium. Tis-
suehomogenate orbloodsample (3ml) wasextracted
by 5 ml pentane. The pentane layer was then sepa-
rated by centrifugation at lOOOg for 5 min. A gas
chromatograph equipped with an electron capture
detector was used for the quantitation of chloro-
form in each sample, with bromodichloromethane
being used as the internal standard.
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Results
Kinetics of Cl Compounds in the Rat
The rate constantand T1/2forabsorptionand elim-
ination from plasma of Cl compounds are shown in
Table 1. The rate constant for absorption was high-
est for 36CI02 (3.77 ±0.24/hr) followed by 26CI03-,
36C102-, and lowest for HO3CI (0.157±0.001/hr).
The T112 for absorption, which is inversely propor-
tional to the rate constant, was longest for HO"6Cl
(4.42 ± 1.31 hr), followed by 36C102, 36C103-, and
was shortest for 36C102 (0.18 ± 0.01 hr). For elimi-
nation from plasma, the rate constant was highest
for 36C02- (0.02 ± 0.002/hr), followed by 36CI03-,
36CIO2and H036CI (0.009 ± 0.001/hr). The T/2elimi-
nation from plasma was longest for H036CI (77.0
± 8.8 hr), followed by 36CIO2, 36CIO3-, and 36CIO2-
(35.2 ± 3.0 hr).
Distribution of Cl Compounds in the
Rat
The distribution of 36CI compounds after 72 hr
from the time of oral administration is shown in
Table 2. Values are expressed as a percentage of
Table 1. Kinetic constants of chlorine dioxide, chlorite, chlorate and chlorine in the rat.a
Absorption, hr-' Elimination, hr-1
Treatment Rate constant T½/2 Rate constant Ti/2
36C102 (100 mg/I.) 3.77 ± 0.24 0.18 + 0.01 0.0158 ± 0.0008 43.9 ± 2.3
3Cl02- (10 mg/O.) 0.198 ± 0.06 3.50 ± 1.06 0.0197 ± 0.0017 35.2 ± 3.0
36C103- (5 mg/I.) 0.399 ± 0.151 1.74 + 0.66 0.019 ± 0.003 36.7 ± 5.8
H036C1 (250 mg/I.) 0.157 ± 0.001 4.42 ± 1.31 0.009 ± 0.001 77.0 ± 8.8
aValues were calculated from the time course of the elimination from rat plasma; n = 4 rats per treatment.
Table 2. Chlorine dioxide, chlorite, chorate and chlorine distribution in the rat.
Percentage of initial dosea
36C102 36CIO-2 36CIO-3 H036CI
Tissue (100 mg/l.) (10 mg/l.) (5 mg/I.) (250 mg/I.)
Plasma 0.72 ± 0.02 0.55 ± 0.038 0.68 ± 0.09 0.77 ± 0.04
Packed cells b 0.63 ± 0.11 0.23 ± 0.02
Whole blood 0.64 ± 0.01 0.57 ± 0.05
Kidney 0.81 ± 0.15 0.30 ± 0.06 0.42 ± 0.07 0.39 ± 0.03
Lung 0.74 ± 0.15 0.37 ± 0.04 0.45 ± 0.07 0.34 ± 0.02
Stomach 0.70 ± 0.15 0.43 ± 0.07 0.46 ± 0.05 0.20 ± 0.03
Deodenum 0.29 ± 0.07 0.31 ± 0.01 0.34 ± 0.04 0.28 ± 0.04
Ileum 0.48 ± 0.09 0.17 ± 0.03 0.21 ± 0.02 0.14 ± 0.02
Liver 0.38 ± 0.09 0.06 ± 0.03 0.20 ± 0.03 0.20 ± 0.01
Spleen 0.25 ± 0.04 0.22 ± 0.02 0.29 ± 0.04 0.23 ± 0.02
Bone marrow 0.16 ± 0.03 0.09 ± 0.03 0.15 ± 0.03 0.40 ± 0.01
Testes 0.39 ± 0.04 0.45 ± 0.07 0.37 ± 0.02
Skin 0.38 ± 0.06 0.42 ± 0.10 0.32 ± 0.03
Carcass 0.25 + 0.04 0.21 ± 0.02 0.18 ± 0.003
aValues represent mean ± SE as percentage of the initial dose from four rats per treatment after 72 hr.
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Table 3. Metabolism of chlorine dioxide, chlorite and chlorate in rat urine.
Percentage of initial dosea
Treatment C1- CIO-2 CIO-3
36C102 (100 mg/I.) 26.93 ± 1.6 3.46 ± 1.0 0.73 ± 0.73
36ClO2-(100 mg/I.) 31.55 ± 4.5 6.0 ± 0.6 b
36CI03-(5 mg/I.) 20.50 ± 0.7 3.95 ± 2.7 8.2 ± 2.9
aValues represent the mean ± SE as percentage of the initial dose from four rats per treatment, throughout the 72 hr studied.
bNone detected.
the initial dose. The distribution of 36C102 was
highest in the kidney, followed by lung, plasma,
stomach, ileum, liver, duodenum, spleen and bone
marrow, while the distribution ofHO36C1 was high-
est in plasma, followed by bone marrow, kidney,
testes, lung, skin, duodenum, spleen, stomach, liver,
carcass and ileum. The distribution of36C102- was
highest in plasma, followed by stomach, testes,
skin, lung, duodenum, kidney, carcass, spleen, ileum,
bonemarrowandliver. Inthecaseof36CI03-, plasma
was highest, followed by stomach, lung, testes,
kidney, skin, duodenum, spleen, ileum, carcass,
liver and bone marrow.
In whole blood, when plasma was separated from
packed cells, radioactivity was divided more or less
Table 4. Excretion ofchlorine dioxide, chlorite, chlorate and
chlorine in the rat.
Percentage of initial dosea
Treatment Urine Feces
0Cl02 (100 mg/i.) 30.81 ± 0.8 10.10 ± 1.7
36CI02-(10 mg/I.) 34.51 ± 1.4 4.75 ± 1.0
36C103-(5 mg/I.) 40.14 ± 2.14 3.14 ± 1.0
H036C1 (250 mg/I.) 21.52 ± 2.51 7.09 ± 0.24
aValues represent the mean ± SE as percentage ofthe initial
dose from fourrats pertreatment, throughout the 72 hrstudied.
36Cl was not detected in expired air.
evenlybetween the plasmaand packed cells (0.55 +
0.038 and 0.63 + 0.11% ofinitial dose, respectively)
for36ClO2-,whereasfor36CIO3-, radioactivityprefer-
entially accumulated in the plasma (0.68 ± 0.09% of
initial dose vs. 0.23 ± 0.02% in the packed cells).
Metabolism of Cl Compounds
The administered 36CI compounds are found as
various metabolites in rat urine, as shown in Table
3. After 72 hr from the time of administration,
36C102and36CI03-arefoundinurineasC1,C1O2-and
C103-whereas36ClO2-isfoundasCl-andC102-. Inall
three cases, Cl- is the major metabolite (approxi-
mately 87, 84 and 64% of the total radioactivity
foundinurinefor36CIO2,36CIO2-and36CIO3-, respec-
tively).
Excretion of Cl Compounds
The total ofthe 36CI compounds recovered in the
urine and feces 72 hr after administration was
determined for each compound and calculated as
the percentage of the initial dose. In the case of
36C102, 75% ofthe recovered dose was found in the
urine, while25% wasfoundinthefeces. For36CIO2-,
87 and 13% was found in urine and feces, respec-
tively; and for H036CI, 76 and 24% was found in
urine and feces, respectively (Table 4).
Table 5. Effect of chlorine dioxide, chlorite and chlorate on the formation of chloroform in rat blood and organs.
Concentration,
Treatmenta mg/l. n Organ Effects
C102 10 4 Blood No effect
100 7 Blood Increased
10 4 Liver, kidney, spleen, brain No effect
10 4 Testes Increased
100 7 Liver, testes, brain Increased
C102- 100 7 Blood No effect
100 7 Liver, brain Increased
C103- 100 9 Blood No effect
100 9 Liver Increased
aRats were treated with chlorine dioxide and its metabolites daily for one year.
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36C1 compounds were not found in the expired air
of any treatment group throughout the 72 hr time
period.
Effect of Cl Compounds on the
Formation of Chloroform in Rat Blood
and Organs
Table 5 shows the effects of chronic treatment
with chlorine dioxide and its metabolites for one
year on the formation of chloroform in rat blood,
liver, kidney, spleen, brain and testes. A concen-
tration of100 mg/l. C102 daily in the drinking water
caused an increase in chloroform levels in blood,
liver, testes and brain. A concentration of 10 mg/l.
C102increased chloroformlevels inrattestes, while
levels in blood, liver, kidney, spleen and brain
remained unchanged. Treatment of rats with 100
mg/l. C102- for one year elevated chloroform levels
in the liver and brain, while the levels in blood were
notaffected. Treatmentwith 100mg/l. Cl03-increased
liver but not blood chloroform concentrations after
one year.
Discussion
From the kinetics study, it is apparent that C102
and its metabolites (C102- and C1030 are more rap-
idly absorbed into the bloodstream than HOC1. The
effect is very pronounced when comparing C102
itself with HOCI. Likewise, HOCI is more slowly
eliminated from rat plasma than C102 orits metabo-
lites.
The distribution study revealed that although
plasma and whole blood contain the highest activi-
ty, the bone marrow contained far less in 36C102,
3C102- and 36C103 treatment, while HOCI had a
higheractivity inbone marrow. The high activityin
testes, even after 72 hr, indicates a possible phar-
macologic action at this site. Effects of these com-
pounds on the reproductive system are currently in
progress in our laboratory.
It is important to indicate that after 72 hr, high
amounts of radioactivity were still found in the
stomach, duodenum and ileum.
The Cl compounds studied are eliminated mainly
bykidney and intestinal routes, since no radioactiv-
ity was found in expired air. For H036C1 and 36C102
treatment, about 75% of the recovered dose was
foundintheurine; inthecaseof36CI02-and 36CI03 ,
about 90% of the recovered dose was in the urine.
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